234 related articles for article (PubMed ID: 18390703)
1. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
[TBL] [Abstract][Full Text] [Related]
2. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
[TBL] [Abstract][Full Text] [Related]
3. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
4. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.
Liang L; Porter EM; Sha WC
J Exp Med; 2002 Jul; 196(1):97-108. PubMed ID: 12093874
[TBL] [Abstract][Full Text] [Related]
6. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
7. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
[TBL] [Abstract][Full Text] [Related]
8. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein.
Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG
J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355
[TBL] [Abstract][Full Text] [Related]
10. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival.
Akbari O; Stock P; Meyer EH; Freeman GJ; Sharpe AH; Umetsu DT; DeKruyff RH
J Immunol; 2008 Apr; 180(8):5448-56. PubMed ID: 18390727
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human inducible costimulator ligand expression and function.
Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
[TBL] [Abstract][Full Text] [Related]
12. B7h is required for T cell activation, differentiation, and effector function.
Nurieva RI; Mai XM; Forbush K; Bevan MJ; Dong C
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14163-8. PubMed ID: 14615582
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway.
Futamatsu H; Suzuki J; Kosuge H; Yokoseki O; Kamada M; Ito H; Inobe M; Isobe M; Uede T
Cardiovasc Res; 2003 Jul; 59(1):95-104. PubMed ID: 12829180
[TBL] [Abstract][Full Text] [Related]
14. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules.
Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M
J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.
Akbari O; Freeman GJ; Meyer EH; Greenfield EA; Chang TT; Sharpe AH; Berry G; DeKruyff RH; Umetsu DT
Nat Med; 2002 Sep; 8(9):1024-32. PubMed ID: 12145647
[TBL] [Abstract][Full Text] [Related]
17. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
18. Interaction of B7RP-1 with ICOS negatively regulates antigen presentation by B cells.
Wahl P; Schoop R; Horan TP; Yoshinaga SK; Wüthrich RP
Inflammation; 2003 Aug; 27(4):191-200. PubMed ID: 14527172
[TBL] [Abstract][Full Text] [Related]
19. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
20. The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
Marczynska J; Ozga A; Wlodarczyk A; Majchrzak-Gorecka M; Kulig P; Banas M; Michalczyk-Wetula D; Majewski P; Hutloff A; Schwarz J; Chalaris A; Scheller J; Rose-John S; Cichy J
J Immunol; 2014 Sep; 193(6):2753-63. PubMed ID: 25108021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
